Akaption SRL
The score of Akaption shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +74 % Total assets +16 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Akaption's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 0 € | ||||
| Net result | 156,542 € | ||||
| Equity | 296,307 € | ||||
| Cash | 241,514 € | ||||
| EBITDA | 132,925 € | ||||
| Total assets | 967,311 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Jun 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 13 May 2024
- Year ended 31 Dec 2022filed on 09 May 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Akaption's financial analysis
- Solvency30.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Akaption
Akaption's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0665.738.120
- VAT number
- BE0665738120
- Peppol
- Registered · 0208:0665738120 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Nov 2016
- Registered office
- 4260 Braives
- Latest accounts
- 2025 · filed on 05 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Akaption (SRL) has been based in Braives since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports revenue of 0 €, a net profit of 156,542 € and equity of 296,307 €. Its solvency stands at 30.6%, below the median of its sector (41.5%).
Companies similar to Akaption
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Demaphar Retail sale of pharmaceutical products Mons · balance sheet 965,578 €
- Demuphar Retail sale of pharmaceutical products Ghent · balance sheet 978,525 €
- D'Haen Pharma Retail sale of pharmaceutical products Zottegem · balance sheet 987,565 €
- G-PAS Holding Retail sale of pharmaceutical products Brasschaat · balance sheet 992,375 €
- Cassifarma Retail sale of pharmaceutical products Leuven · balance sheet 942,826 €
- Cosom Retail sale of pharmaceutical products Genappe · balance sheet 931,343 €
- PharmaLEDA Retail sale of pharmaceutical products Ixelles · balance sheet €1.01m
Frequently asked questions about Akaption
What is the revenue of Akaption?
According to the 2025 annual accounts filed with the NBB, the revenue of Akaption amounts to 0 €.
What is the VAT number of Akaption?
In Belgium, the VAT number is the company number prefixed with BE: BE0665738120 for Akaption, if the company is VAT-registered. Its company number (CBE) is 0665.738.120.
Where is the registered office of Akaption?
According to the CBE register, the registered office of Akaption is in 4260 Braives.
What is the equity of Akaption?
At the close of the 2025 financial year, the equity of Akaption amounts to 296,307 €, a solvency of 30.6% of total assets.
Who manages Akaption?
The register lists 1 active mandates at Akaption. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Akaption
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →